• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2021 Jun 4;8(7):ofab300.
doi: 10.1093/ofid/ofab300. eCollection 2021 Jul.
Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates


Ahmed M Moustafa[SUP] 1 2 [/SUP], Colleen Bianco[SUP] 1 [/SUP], Lidiya Denu[SUP] 1 [/SUP], Azad Ahmed[SUP] 3 [/SUP], Susan E Coffin[SUP] 1 [/SUP], Brandy Neide[SUP] 1 [/SUP], John Everett[SUP] 4 [/SUP], Shantan Reddy[SUP] 4 [/SUP], Emilie Rabut[SUP] 5 [/SUP], Jasmine Deseignora[SUP] 5 [/SUP], Michael D Feldman[SUP] 6 [/SUP], Kyle G Rodino[SUP] 6 [/SUP], Frederic Bushman[SUP] 4 [/SUP], Rebecca M Harris[SUP] 6 7 [/SUP], Josh Chang Mell[SUP] 3 [/SUP], Paul J Planet[SUP] 1 7 8 [/SUP]



Affiliations

Abstract

We report the genome of a B.1.1.7+E484K severe acute respiratory syndrome coronavirus 2 from Southeastern Pennsylvania and compare it with all high-coverage B.1.1.7+E484K genomes (n = 235) available. Analyses showed the existence of at least 4 distinct clades of this variant circulating in the United States and the possibility of at least 59 independent acquisitions of the E484K mutation.

Keywords: B.1.1.7+E484K; convergent; escape mutation; vaccine; variant of concern.
 
Back
Top Bottom